E-LIB Suche - Ergebnisse für: Abitbol, A.

1

IMPACT OF GLP-1 RECEPTOR AGONISTS COMPARED TO BASAL INSULIN..:

Abitbol, A. ; Bradley, R. ; Auerbach, P..
Canadian Journal of Diabetes. 47 (2023) 7 - p. S105-S106 , 2023

Link: https://doi.org/10.1016/..

2

IMPACT OF GLP-1 RECEPTOR AGONISTS COMPARED TO BASAL INSULIN..:

Abitbol, A. ; Bradley, R. ; Auerbach, P..
Canadian Journal of Cardiology. 39 (2023) 10 - p. S135 , 2023

Link: https://doi.org/10.1016/..

3

WALANT technique versus locoregional anesthesia in the surg..:

Ruterana, P. ; Abitbol, A. ; Castel, L.-C..
Hand Surgery and Rehabilitation. 41 (2022) 2 - p. 220-225 , 2022

Link: https://doi.org/10.1016/..

4

Applying the WALANT technique to surgical treatment of dist..:

Abitbol, A. ; Merlini, L. ; Masmejean, E.H..
Hand Surgery and Rehabilitation. 40 (2021) 3 - p. 277-282 , 2021

Link: https://doi.org/10.1016/..

5

Prolonged waiting times for surgery in patients with endome..:

Mitric, C. ; Wissing, M. ; Matanes, E....
Gynecologic Oncology. 159 (2020) - p. 214-215 , 2020

Link: https://doi.org/10.1016/..

6

Predicting histologic upgrading in endometrial cancer:

Matanes, E. ; Mitric, C. ; Wissing, M....
Gynecologic Oncology. 159 (2020) - p. 214 , 2020

Link: https://doi.org/10.1016/..

7

Dose dense carboplatin-paclitaxel improves survival in pati..:

Matanes, E. ; Mitric, C. ; Amajoud, Z....
Gynecologic Oncology. 159 (2020) - p. 213 , 2020

Link: https://doi.org/10.1016/..

8

Sentinel lymph node sampling is associated with better surv..:

Matanes, E. ; Mitric, C. ; Amajoud, Z....
Gynecologic Oncology. 159 (2020) - p. 215-216 , 2020

Link: https://doi.org/10.1016/..

9

Sentinel lymph nodes sampling in patients with high-risk en..:

Matanes, E. ; Mitric, C. ; Wissing, M....
Gynecologic Oncology. 159 (2020) - p. 215 , 2020

Link: https://doi.org/10.1016/..

10

Dose dense chemotherapy might be the only modifiable factor..:

Matanes, E. ; Mitric, C. ; Amajoud, Z....
Gynecologic Oncology. 159 (2020) - p. 213-214 , 2020

Link: https://doi.org/10.1016/..

11

Gender differences in how physicians access and process inf..:

Gotlieb, R. ; Abitbol, J. ; How, J.A....
Gynecologic Oncology Reports. 27 (2019) - p. 50-53 , 2019

Link: https://doi.org/10.1016/..

12

Lower uterine segment involvement in non-endometrioid endom..:

Kogan, L. ; Octeau, D. ; Amajoud, Z....
Gynecologic Oncology. 149 (2018) - p. 169-170 , 2018

Link: https://doi.org/10.1016/..

13

Survival outcomes of patients with high-grade endometrial c..:

How, J.A. ; Lau, S. ; Salvador, S...
Gynecologic Oncology. 149 (2018) - p. 105-106 , 2018

Link: https://doi.org/10.1016/..

14

The predictive value of CA-125 during neoadjuvant chemother..:

Kessous, R. ; Abitbol, J. ; Kogan, L....
Gynecologic Oncology. 149 (2018) - p. 165-166 , 2018

Link: https://doi.org/10.1016/..

15

GOC2: A multi-centre prospective trial comparing open, lapa..:

Bernardini, M.Q. ; Gien, L.T. ; Giede, C....
Gynecologic Oncology. 145 (2017) - p. 54 , 2017

Link: https://doi.org/10.1016/..